[Federal Register Volume 78, Number 119 (Thursday, June 20, 2013)]
[Notices]
[Pages 37241-37242]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-14458]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Noramco, Inc. (GA)

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 21, 2012, Noramco, 
Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Opium tincture (9630), a basic class of controlled 
substance listed in schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substance,

[[Page 37242]]

may file comments or objections to the issuance of the proposed 
registration pursuant to 21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administrator, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than August 19, 2013.

     Dated: June 7, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-14458 Filed 6-19-13; 8:45 am]
BILLING CODE 4410-09-P